Vaccine delays and interest rate rise risks fail to dampen market exuberance – for now

• Markets have been fairly relaxed about vaccination roll-out delays but could still be spooked if a new virus strain proves resistant
• A sharp rise in interest rates, particularly as a result of inflation, could also prompt a damaging sell-off